| Title |
A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol
|
|---|---|
| Published in |
BMC Infectious Diseases, October 2020
|
| DOI | 10.1186/s12879-020-05485-7 |
| Pubmed ID | |
| Authors |
Sergio Fragoso-Saavedra, David A. Iruegas-Nunez, Alejandro Quintero-Villegas, H. Benjamín García-González, Isaac Nuñez, Sergio L. Carbajal-Morelos, Belem M. Audelo-Cruz, Sarahi Arias-Martínez, Yanink Caro-Vega, Juan José Calva, Verónica Luqueño-Martínez, Alejandra González-Duarte, Brenda Crabtree-Ramírez, José C. Crispín, Juan Sierra-Madero, Pablo F. Belaunzarán-Zamudio, Sergio I. Valdés-Ferrer |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Saudi Arabia | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 113 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 18 | 16% |
| Researcher | 15 | 13% |
| Student > Master | 10 | 9% |
| Other | 9 | 8% |
| Student > Ph. D. Student | 7 | 6% |
| Other | 17 | 15% |
| Unknown | 37 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 35 | 31% |
| Nursing and Health Professions | 12 | 11% |
| Environmental Science | 3 | 3% |
| Engineering | 3 | 3% |
| Immunology and Microbiology | 2 | 2% |
| Other | 14 | 12% |
| Unknown | 44 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2022.
All research outputs
#6,384,750
of 23,555,482 outputs
Outputs from BMC Infectious Diseases
#1,923
of 7,841 outputs
Outputs of similar age
#138,944
of 417,919 outputs
Outputs of similar age from BMC Infectious Diseases
#45
of 155 outputs
Altmetric has tracked 23,555,482 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 7,841 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 417,919 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 155 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.